Guyotat D - Search Results

1

In vitro effects of recombinant hemopoietic growth factors on progenitor cells from patients with myelodysplastic syndromes.

Thomas X, Guyotat D, Campos L, Shi ZH, Vila L, Ehrsam A, Fiere D. Thomas X, et al. Among authors: guyotat d. Leuk Res. 1991;15(1):29-36. doi: 10.1016/0145-2126(91)90141-f. Leuk Res. 1991. PMID: 1705306

2

Myeloid differentiation antigens identify leukemic cell subpopulations with different cell cycle characteristics.

Campos L, Ffrench M, Guyotat D. Campos L, et al. Among authors: guyotat d. Leukemia. 1990 Jan;4(1):60-2. Leukemia. 1990. PMID: 1688640

3

Myeloid surface antigen expression in adult acute lymphoblastic leukemia.

Guyotat D, Campos L, Shi ZH, Charrin C, Treille D, Magaud JP, Fiere D. Guyotat D, et al. Leukemia. 1990 Sep;4(9):664-6. Leukemia. 1990. PMID: 1697640

4

Response of hematopoietic precursor cells to hematopoietic growth factors in the myelodysplastic syndromes.

Thomas X, Campos L, Bonnier S, Troncy J, Guyotat D, Fière D. Thomas X, et al. Among authors: guyotat d. Nouv Rev Fr Hematol (1978). 1990;32(5):345-7. Nouv Rev Fr Hematol (1978). 1990. PMID: 2099409

5

Myelodysplastic syndromes: a study of surface markers and in vitro growth patterns.

Guyotat D, Campos L, Thomas X, Vila L, Shi ZH, Charrin C, Gentilhomme O, Fiere D. Guyotat D, et al. Am J Hematol. 1990 May;34(1):26-31. doi: 10.1002/ajh.2830340107. Am J Hematol. 1990. PMID: 2327401

6

Expression of CD 19 antigen on acute monoblastic leukemia cells at diagnosis and after TPA-induced differentiation.

Campos L, Guyotat D, Larese A, Mazet L, Bourgeot JP, Ehrsam A, Fiere D. Campos L, et al. Among authors: guyotat d. Leuk Res. 1988;12(5):369-72. doi: 10.1016/0145-2126(88)90054-9. Leuk Res. 1988. PMID: 2454379

7

Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon-alpha.

Michallet M, Thiébaut A, Philip I, Charrin C, Vigouroux C, Thomas X, Bilger K, Belhabri A, Guyotat D, Corront B, Salles B, Dumontet C, Péaud PY, Vilque JP, Devidas A, Fière D. Michallet M, et al. Among authors: guyotat d. Leukemia. 2000 Dec;14(12):2064-9. doi: 10.1038/sj.leu.2401956. Leukemia. 2000. PMID: 11187894 Clinical Trial.

8

Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia.

Thomas X, Campos L, Mounier C, Cornillon J, Flandrin P, Le QH, Piselli S, Guyotat D. Thomas X, et al. Among authors: guyotat d. Leuk Res. 2005 Sep;29(9):1049-58. doi: 10.1016/j.leukres.2005.02.010. Epub 2005 Mar 23. Leuk Res. 2005. PMID: 16038731

9

Specific binding of anti-N-acetyllactosamine monoclonal antibody 1B2 to acute myeloid leukaemia cells.

Campos L, Portoukalian J, Bonnier S, Shi ZH, Calmard-Oriol P, Treille D, Guyotat D. Campos L, et al. Among authors: guyotat d. Eur J Cancer. 1992;28(1):37-41. doi: 10.1016/0959-8049(92)90380-k. Eur J Cancer. 1992. PMID: 1567687

10

Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.

Guyotat D, Shi ZH, Campos L, Rabat M, Bonnier S, Poncelet P, Laurent JC, Fiere D. Guyotat D, et al. Bone Marrow Transplant. 1990 Dec;6(6):385-90. Bone Marrow Transplant. 1990. PMID: 1982926

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters